Today: 19 May 2026
Nasdaq ends 2025 on a down note; markets closed today as jobs report, CPI loom
1 January 2026
2 mins read

Nasdaq ends 2025 on a down note; markets closed today as jobs report, CPI loom

NEW YORK, January 1, 2026, 08:07 ET — Market closed

  • Nasdaq Composite fell 0.8% on Wednesday to finish 2025 at 23,241.99, with trading shut on Thursday for New Year’s Day
  • A late-December pullback capped a strong year for big U.S. indexes, led by AI-linked optimism
  • Investors turn to Jan. 9 payrolls, Jan. 13 CPI and the start of bank earnings for the next market catalyst

U.S. stock markets are closed on Thursday for New Year’s Day after the Nasdaq Composite slipped 0.8% in the final session of 2025, ending at 23,241.99. The S&P 500 fell 0.7% to 6,845.50 and the Dow Jones Industrial Average lost 0.6% to 48,063.29.

The timing matters because the Nasdaq heads into 2026 near record territory after a year in which bets on artificial intelligence powered many of the biggest winners. The late-year dip is the first signal investors will test against hard data on inflation, the labor market and interest rates.

The first trading week of January also tends to bring deeper liquidity — more buyers and sellers, and fewer distortions from holiday-thinned flows. That makes the next session a quick read on whether year-end selling was housekeeping or a change in risk appetite.

Profit-taking weighed on tech and energy shares on Wednesday and extended a four-session Nasdaq slide, leaving the market without a traditional “Santa Claus rally,” a seasonal late-December and early-January lift. Microsoft fell 0.8% and EQT slipped 1.9%, while Vanda Pharmaceuticals jumped after the FDA approved its drug to prevent motion-induced vomiting; volume ran at 11.17 billion shares versus a 20-day average of 15.8 billion, Reuters reported. “I do not expect that the last few days will have so much bearing on the performance of the next year,” said Giuseppe Sette, co-founder and president of Reflexivity. Reuters

Even with Wednesday’s decline, the Nasdaq still finished 2025 up about one-fifth, reflecting a market that repeatedly leaned back into growth stocks after setbacks. That leaves valuations exposed to any surprise in rates or earnings once the calendar turns.

Investors have also treated the “AI trade” — shorthand for crowding into companies seen as key beneficiaries of artificial intelligence — as a long-duration bet. Those trades usually react fastest when Treasury yields rise, because higher yields can reduce the value of profits expected far in the future.

Before the next session, markets have a clear macro schedule to price. The U.S. employment report for December is scheduled for Jan. 9, followed by the December consumer price index on Jan. 13, according to the Bureau of Labor Statistics calendar.

The next Federal Reserve policy decision is set for Jan. 27-28, the Fed’s calendar shows, keeping rate expectations front and center for tech-heavy indexes like the Nasdaq.

Earnings are the other near-term swing factor, with big banks set to start reporting mid-month. JPMorgan Chase said it will discuss fourth-quarter results on Jan. 13, and Bank of America lists Jan. 14 as its next quarterly earnings release date.

From a technical standpoint, the Nasdaq ended the year a bit above the 23,000 mark, a round-number level many traders watch as an informal support zone. A quick break below it after the holiday could draw in short-term sellers, while a firm hold would suggest the pullback was contained.

Stock Market Today

  • Yacktman Asset Management Cuts Alphabet Inc. Stake Amid Mixed Institutional Moves
    May 19, 2026, 2:13 PM EDT. Yacktman Asset Management LP reduced its stake in Alphabet Inc. (NASDAQ:GOOG) by 3.1% in Q4, selling 36,606 shares and holding 1,129,807 shares valued at $354.5 million, representing 5% of its portfolio. Other institutional investors showed varied activity with Brighton Jones LLC and Worldquant Millennium Advisors LLC increasing their holdings significantly. Alphabet's stock saw multiple analyst ratings, including 'outperform' and 'buy' with target prices ranging from $345 to $450, reflecting positive sentiment from firms like Scotiabank, TD Cowen, and Deutsche Bank. Institutional investors own 27.26% of Alphabet's shares. The stock remains a top focus amid ongoing trading by hedge funds and asset managers.

Latest articles

Why Recursion Stock Just Hit a 52-Week Low — and the FDA Update Traders Are Waiting For

Why Recursion Stock Just Hit a 52-Week Low — and the FDA Update Traders Are Waiting For

19 May 2026
New York, May 19, 2026, 2:04 PM EDT Recursion Pharmaceuticals shares fell in Tuesday afternoon trading after touching a fresh 52-week low, keeping pressure on one of the better-known AI drug-discovery names even as the company points to clinical progress and a cash runway into 2028. The stock was recently down about 2.2% at $2.825, after trading as low as $2.77, with volume above 10 million shares and a market value near $1.49 billion. Investing.com reported earlier Tuesday that Recursion had hit a 52-week low at $2.79 and said the shares were down about 36% over the past year. That
Wall Street’s Top Picks for U.S. Stocks as Yields Stay High

Wall Street’s Top Picks for U.S. Stocks as Yields Stay High

19 May 2026
U.S. stocks fell Tuesday as the 10-year Treasury yield reached its highest point since January 2025, pressuring growth shares. Nvidia drew the most attention ahead of its earnings, with options markets pricing in a possible $355 billion swing in value. Dell highlighted new AI infrastructure partnerships, while ServiceNow received a fresh Buy rating from Bank of America.
Nvidia’s Earnings Could Make or Break the AI Stock Trade

Nvidia’s Earnings Could Make or Break the AI Stock Trade

19 May 2026
Nvidia rose 0.8% ahead of its earnings report, while CoreWeave dropped 3.7% after Google and Blackstone announced a $5 billion U.S. AI cloud venture using Google’s custom TPUs. The new venture will offer 500 megawatts of data-center capacity by 2027. AMD and Micron also gained, but Microsoft and Broadcom slipped. Investors are watching whether Nvidia can maintain dominance as competition in AI inference intensifies.
Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Previous Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

BYD stock slips in Shenzhen after sales growth slows to a five-year low
Next Story

BYD stock slips in Shenzhen after sales growth slows to a five-year low

Go toTop